TriSalus Life Sciences appoints Liselotte Hyveled to Board, effective May 6

TriSalus Life Sciences, Inc.

Board size increased to ten directors; Hyveled appointed as Class I director, term expiring at 2024 annual meeting.
Annual cash retainer of $50,000 for Board service; grant of option to purchase 35,000 shares vesting over three years.
Additional $7,500 annual retainer for each of Nominating Committee and Science & Technology Committee membership.
No arrangements or transactions requiring disclosure under Item 404(a); standard indemnity agreement entered.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.